COMMUNIQUÉS West-GlobeNewswire

Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease

16/05/2018 - 16:01

Medtronic Received IDE Approval from FDA to Generate Clinical Evidence with Resolute Onyx DES to Support Future Application for Expanded Indication in U.S. DUBLIN - May 16, 2018 - Medtronic plc (NYSE: MDT) today [...]

Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä

16/05/2018 - 15:41

ORION CORPORATION MANAGERS' TRANSACTIONS 16 MAY 2018 at 16.40 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]

Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä

16/05/2018 - 15:31

ORION CORPORATION MANAGERS' TRANSACTIONS 16 MAY 2018 at 16.30 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]

Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia

16/05/2018 - 15:14

– ENTERS INTO EXCLUSIVE SUPPLY AGREEMENT WITH APHRIA – – COLCANNA TO BE FIRST TO MARKET WITH APHRIA’S PHARMACEUTICAL GRADE CBD OIL IN COLOMBIA – TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the [...]

Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights

16/05/2018 - 15:10

Further data on larazotide’s mechanism of action, dose response and pharmacology expected at DDW (June 2-5) in Washington D.C. Addition to senior management of June Almenoff, M.D., PhD. as COO and CMO (former principal [...]

Sienna Biopharmaceuticals to Present SNA-125 Pre-Clinical Psoriasis Data as Late-Breaker at the International Investigative Dermatology Congress

16/05/2018 - 15:05

WESTLAKE VILLAGE, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that pre-clinical data from the Company’s topical product candidate SNA-125, a novel, selective [...]

Crisp Regional Health, Inc. Selects Cerner Integrated EHR to Support Improved Patient Care

16/05/2018 - 15:01

CORDELE, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Crisp Regional Health, Inc. has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue cycle [...]

Zealand Pharma - Interim report for the first quarter of 2018

16/05/2018 - 15:00

Company announcement - No. 14 / 2018 Zealand Pharma - Interim report for the first quarter of 2018 Copenhagen, May 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), the Copenhagen-based company [...]

Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference

16/05/2018 - 15:00

OXFORD, United Kingdom and MARLBOROUGH, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, [...]

Media Advisory: Monday, May 21 - 2018 Diabetes Innovation Challenge Pitch Off

16/05/2018 - 15:00

ROYAL SONESTA BOSTON 3:00 PM – 5:00 PM $250,000 IN CASH AND IN-KIND PRIZES TO BE AWARDED BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Ten finalists, all academic researchers and early stage companies, will compete on May 21 [...]

Progyny and Happify Health Give People Dealing with Infertility New Digital Emotional Support Tools

16/05/2018 - 15:00

NEW YORK, May 16, 2018 (GLOBE NEWSWIRE) -- For many people dealing with infertility, the emotional impact may be as challenging as the medical roadblocks. But there are resources that can help. Progyny , the leading [...]

Devonian Health Group Announces Canadian Patent for its Purgenesis™ anti-aging treatment

16/05/2018 - 14:45

QUEBEC CITY, May 16, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) today announced that the Canadian Intellectual Property Office issued a Notice of Allowance [...]

Groupe Santé Devonian reçoit l’avis d’acceptation pour le brevet canadien de son traitement anti-âge Purgenesis(MC)

16/05/2018 - 14:45

QUÉBEC, 16 mai 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonçait aujourd’hui avoir reçu un avis d’acceptation de l’Office de la propriété intellectuelle [...]

LIDDS signs license agreement for prostate cancer drug Liproca® Depot with major Chinese pharma company

16/05/2018 - 14:40

UPPSALA, SWEDEN - LIDDS AB (publ) has signed a license agreement for Liproca® Depot with Jiangsu Ambition Medical, a Chinese pharmaceutical company specializing in global collaborations and in-licensing. Liproca® Depot [...]

Corcept Therapeutics Announces Presentations at the American Association of Clinical Endocrinologists 27th Annual Congress

16/05/2018 - 14:30

MENLO PARK, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe [...]

Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease at the American Thoracic Society 114th International Conference

16/05/2018 - 14:30

WARREN, N.J., May 16, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will present the [...]

Albireo Enrolls First Patient in Phase 3 PFIC Trial of A4250

16/05/2018 - 14:30

— Pivotal program in rare and life-threatening pediatric liver disorder underway — — Data intended to provide support for anticipated drug approval applications in US and EU — BOSTON, May 16, 2018 (GLOBE NEWSWIRE) -- [...]

Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists

16/05/2018 - 14:30

Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing [...]

Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update

16/05/2018 - 14:30

ORLANDO, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), an advanced specialty pharmaceutical company engaged in the treatment of serious and debilitating disorders through the [...]